Literature DB >> 4017944

Metabolism of high density lipoproteins reconstituted with [3H]cholesteryl ester and [14C]cholesterol in the rat, with special reference to the ovary.

J E Nestler, M Bamberger, G H Rothblat, J F Strauss.   

Abstract

In order to study the metabolism of high density lipoprotein (HDL)-carried sterol in the rat, human HDL was reconstituted with [14C]cholesterol and [3H]cholesteryl ester. After iv injection into immature PMSG-human CG primed rats pretreated with 4-aminopyrazolopyrimidine and aminoglutethimide, there was time-dependent accumulation of 3H and 14C in various organs which reached a maximum by 15-90 min. On a milligram wet weight basis, uptake of 3H and 14C was greatest in the adrenals, next in ovaries, followed by the liver, with little uptake by kidneys and spleen. On an organ basis, accumulation was greatest by the liver. At 15-45 min post injection, 60% of the 3H in the ovary was in free sterol, indicating hydrolysis of the accumulated cholesteryl esters, whereas 95% of the 3H in serum remained in sterol esters associated with HDL. Coadministration of excess unlabeled HDL, but not human low density lipoprotein, reduced accumulation of radioactivity by the ovaries and adrenals by 60%, indicating a specific and saturable uptake process. Granulosa cells cultured in lipoprotein-deficient medium with reconstituted HDL formed 3H- and 14C-labeled 20 alpha-hydroxypregn-4-en-3-one. Over a 24-h period, utilization of both [14C]cholesterol and [3H]cholesteryl ester was linear, but rates of utilization of the two sterol moieties were not parallel. There was preferential uptake and utilization of free sterol. A dose-response study demonstrated a Michaelis-Menten constant (Km) of 40-60 micrograms sterol/ml for both free and esterified cholesterol. Lysosomotropic agents (chloroquine and NH4Cl) had no effect on utilization of either free or esterified cholesterol for steroidogenesis but reduced degradation of 125I-labeled low density lipoprotein apoprotein. These findings lend further support to the concept of a distinct HDL pathway in steroidogenic cells of the rat, which involves 1) preferential uptake and utilization of free cholesterol from HDL and 2) does not require lysosomal activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4017944     DOI: 10.1210/endo-117-2-502

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  The preferential uptake of very-low-density lipoprotein cholesteryl ester by rat liver in vivo.

Authors:  J C Holder; V A Zammit; D S Robinson
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

2.  Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat.

Authors:  K T Landschulz; R K Pathak; A Rigotti; M Krieger; H H Hobbs
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

3.  Cellular uptake and catabolism of high-density-lipoprotein triacylglycerols in human cultured fibroblasts: degradation block in neutral lipid storage disease.

Authors:  N Hilaire; A Nègre-Salvayre; R Salvayre
Journal:  Biochem J       Date:  1994-02-01       Impact factor: 3.857

4.  Scavenger receptor class B, type I (SR-BI) is the major route for the delivery of high density lipoprotein cholesterol to the steroidogenic pathway in cultured mouse adrenocortical cells.

Authors:  R E Temel; B Trigatti; R B DeMattos; S Azhar; M Krieger; D L Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

5.  Evaluation of nanolipoprotein particles (NLPs) as an in vivo delivery platform.

Authors:  Nicholas O Fischer; Dina R Weilhammer; Alexis Dunkle; Cynthia Thomas; Mona Hwang; Michele Corzett; Cheri Lychak; Wasima Mayer; Salustra Urbin; Nicole Collette; Jiun Chiun Chang; Gabriela G Loots; Amy Rasley; Craig D Blanchette
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

6.  Formation and characterization of lipid droplets of the bovine corpus luteum.

Authors:  Heather A Talbott; Michele R Plewes; Crystal Krause; Xiaoying Hou; Pan Zhang; William B Rizzo; Jennifer R Wood; Andrea S Cupp; John S Davis
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.